Hankang Capital

  • Investments: 75
  • Funds: 13
  • Grid/power transmission
  • Photovoltaic
  • Digital technology for carbon accounting and consulting

Company profile

Hankang Capital (formerly "Shanghai Jianxin Capital") is a venture capital focusing on the biomedical industry. We pay attention to major diseases and major clinical needs, carry out in-depth research, support pioneering companies with first-class team and technology platform in advance, and provide professional insights, experience and resources in product pipeline, team building, application and registration, clinical trials, etc. to promote them to become leading enterprises in the industry as soon as possible. We have invested in Innocare Pharma Limited, Akeso, Chip Screen, Keymed Biosciences, AbbiskoTherapeutics and other industry leading companies. Hankang Capital has won the honors such as "TOP 100 Venture Capital Institutions", "TOP 20 Healthcare Investment Institutions", and "TOP 50 Venture Capital Institutions Recognized by LP in China" for many times.

Featured "Shuang-Tan" deals

  • Photovoltaic
  • Grid/power transmission
    Yantai Zhuoyue New Energy Science Co
  • Digital technology for carbon accounting and consulting

Investment preference

Recent deals

  • Immuno-tech

    • Investment Round:B+ round
    • Investment Amount:亿级人民币
  • Bio-engine

    • Investment Round:B++ round
    • Investment Amount:200 million RMB
  • Jinkebo Biotechnology

    • Investment Round:translation missing: en.rounds.Pre-A轮
    • Investment Amount:undisclosed
  • Dansheng Pharmaceutical

    • Investment Round:translation missing: en.rounds.A轮
    • Investment Amount:$40 million
  • Shangjian Biotechnology

    • Investment Round:B+ round
    • Investment Amount:Over RMB200 million